Review article · 2024 · Open access
Targeting cytokine and chemokine signaling pathways for cancer therapy
Signal Transduction and Targeted Therapy, 9(1), 176 · Published 21 July 2024 · DOI 10.1038/s41392-024-01868-3
In brief
“Targeting cytokine and chemokine signaling pathways for cancer therapy” is a 2024 review article by Ming Yi and 6 co-authors, published in Signal Transduction and Targeted Therapy. OpenAlex counts 549 citations as of 15 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Signal Transduction and Targeted Therapy.
- Citations
- 549
- Most cited in
- 2026 (265)
- Field-weighted impact
- 19.86
- References
- 648
- Authors
- 7
Abstract
Cytokines are critical in regulating immune responses and cellular behavior, playing dual roles in both normal physiology and the pathology of diseases such as cancer. These molecules, including interleukins, interferons, tumor necrosis factors, chemokines, and growth factors like TGF-β, VEGF, and EGF, can promote or inhibit tumor growth, influence the tumor microenvironment, and impact the efficacy of cancer treatments. Recent advances in targeting these pathways have shown promising therapeutic potential, offering new strategies to modulate the immune system, inhibit tumor progression, and overcome resistance to conventional therapies. In this review, we summarized the current understanding and therapeutic implications of targeting cytokine and chemokine signaling pathways in cancer. By exploring the roles of these molecules in tumor biology and the immune response, we highlighted the development of novel therapeutic agents aimed at modulating these pathways to combat cancer. The review elaborated on the dual nature of cytokines as both promoters and suppressors of tumorigenesis, depending on the context, and discussed the challenges and opportunities this presents for therapeutic intervention. We also examined the latest advancements in targeted therapies, including monoclonal antibodies, bispecific antibodies, receptor inhibitors, fusion proteins, engineered cytokine variants, and their impact on tumor growth, metastasis, and the tumor microenvironment. Additionally, we evaluated the potential of combining these targeted therapies with other treatment modalities to overcome resistance and improve patient outcomes. Besides, we also focused on the ongoing research and clinical trials that are pivotal in advancing our understanding and application of cytokine- and chemokine-targeted therapies for cancer patients.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024). Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduction and Targeted Therapy, 9(1), 176. https://doi.org/10.1038/s41392-024-01868-3
MLA 9
Yi, Ming, et al. “Targeting cytokine and chemokine signaling pathways for cancer therapy.” Signal Transduction and Targeted Therapy, vol. 9, no. 1, 2024, p. 176. https://doi.org/10.1038/s41392-024-01868-3.
Chicago
Yi, Ming, Tianye Li, Mengke Niu, Haoxiang Zhang, Yuze Wu, Kongming Wu, and Zhijun Dai. 2024. “Targeting cytokine and chemokine signaling pathways for cancer therapy.” Signal Transduction and Targeted Therapy 9 (1): 176. https://doi.org/10.1038/s41392-024-01868-3.
Harvard
Yi, M. et al. (2024) ‘Targeting cytokine and chemokine signaling pathways for cancer therapy’, Signal Transduction and Targeted Therapy, 9(1), p. 176. doi:10.1038/s41392-024-01868-3.
IEEE
M. Yi et al., “Targeting cytokine and chemokine signaling pathways for cancer therapy,” Signal Transduction and Targeted Therapy, vol. 9, no. 1, p. 176, 2024, doi: 10.1038/s41392-024-01868-3.
BibTeX
@article{yi2024targeting,
title = {{Targeting cytokine and chemokine signaling pathways for cancer therapy}},
author = {Yi, Ming and Li, Tianye and Niu, Mengke and Zhang, Haoxiang and Wu, Yuze and Wu, Kongming and Dai, Zhijun},
journal = {Signal Transduction and Targeted Therapy},
year = {2024},
volume = {9},
number = {1},
pages = {176},
doi = {10.1038/s41392-024-01868-3},
url = {https://doi.org/10.1038/s41392-024-01868-3}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 21 | |
| 2025 | 263 | |
| 2026 | 265 |
Its field-weighted citation impact is 19.86: it has been cited 19.86 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- cytokine signaling
- chemokine signaling
- cancer therapy
- tumor microenvironment
- antitumor immunity
- tumor growth
- metastasis
- drug resistance
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024). Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduction and Targeted Therapy, 9(1), 176. https://doi.org/10.1038/s41392-024-01868-3
How many times has this paper been cited?
549 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Signal Transduction and Targeted Therapy.
Who wrote this paper?
Ming Yi, Tianye Li, Mengke Niu, Haoxiang Zhang, Yuze Wu, Kongming Wu, Zhijun Dai.
What is the DOI of this paper?
10.1038/s41392-024-01868-3. The permanent link is https://doi.org/10.1038/s41392-024-01868-3.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.